CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Canaccord Genuity Adjusts Price Target on Biogen to $248 From $245, Maintains Buy Rating

Neutral
AI Analysis

Summary

Canaccord Genuity raised its price target on Biogen to $248 from $245 while maintaining a Buy rating.

Importance:2/10
Sentiment:
0.10
analyst_ratingprice_target
Related Companies

Read the original article

Published by yahoo_finance on July 30, 2026 1:57 PM

Read Original